Search Results - "M. Martín-Izquierdo"
-
1
-
2
Ureteritis Cystica: Important Consideration in the Differential Diagnosis of Acute Renal Colic
Published in Clinical Medicine Insights: Case Reports (01-01-2012)“…Ureteritis cystica is an uncommon cause of acute renal pain. The aetiology remains unclear and the diagnosis may be difficult to establish. We report the case…”
Get full text
Journal Article -
3
-
4
Mutational and Clonal Dynamics During Progression from MDS to SAML by Whole-Exome and Targeted-Deep Sequencing
Published in Leukemia research (01-04-2017)Get full text
Journal Article -
5
PF357 A NOVEL REFINED PROGNOSTIC MODEL FOR CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS COMBINING IGH TRANSLOCATIONS AND NEXT‐GENERATION SEQUENCING
Published in HemaSphere (01-06-2019)“…Background: Chromosome 14q32 translocations involving the immunoglobulin heavy chain gene (IGH) are uncommon in chronic lymphocytic leukemia (CLL) patients…”
Get full text
Journal Article -
6
PO-1156: The role of magnetic resonance imaging in prostate cancer
Published in Radiotherapy and oncology (01-11-2020)Get full text
Journal Article -
7
Topic: AS04-MDS Biology and Pathogenesis/AS04i-Microenvironment and stem cell niche
Published in Leukemia research (01-09-2021)Get full text
Journal Article -
8
-
9
Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment
Published in Leukemia research (01-09-2021)Get full text
Journal Article -
10
O20 - Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: INCORPORATION OF COHESIN MUTATIONAL DATA INTO CURRENT IPSS-R CLASSIFICATION REFINES THE PROGNOSTIC STRATIFICATION OF VERY LOW/LOW-RISK MYELODYSPLASTIC SYNDROMES
Published in Leukemia research (01-09-2021)Get full text
Journal Article -
11
TRAF3 alterations are frequent in del‐3′IGH chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features
Published in American journal of hematology (01-07-2022)“…Interstitial 14q32 deletions involving IGH gene are infrequent events in chronic lymphocytic leukemia (CLL), affecting less than 5% of patients. To date,…”
Get full text
Journal Article -
12
Telemonitorización con Claria-Sharesource en diálisis peritoneal durante la pandemia de COVID-19
Published in Nefrología Latinoamericana (14-11-2023)“…Antecedentes/Objetivo: Describir el empleo de la herramienta de telemonitorización con Claria-Sharesource (CSS) durante el periodo de confinamiento por…”
Get full text
Journal Article -
13
87 - Mutational and Clonal Dynamics During Progression from MDS to SAML by Whole-Exome and Targeted-Deep Sequencing
Published in Leukemia research (01-04-2017)Get full text
Journal Article -
14
196 - Mutational Status of Mesenchymal Stem Cell in Myelodysplastic Syndromes Patients
Published in Leukemia research (01-04-2017)Get full text
Journal Article -
15
Mutational Status of Mesenchymal Stem Cell in Myelodysplastic Syndromes Patients
Published in Leukemia research (01-04-2017)Get full text
Journal Article -
16
PB1654 COMPREHENSIVE AND SEQUENTIAL GENETIC ANALYSIS OF B‐CELL ALL REVEALS AN ARRAY OF CHANGES WITH A HIGH INCIDENCE OF TP53 MUTATIONS AND IKZF1 DELETIONS
Published in HemaSphere (01-06-2019)“…Background: B‐Cell Precursor Acute Lymphoblastic Leukemia (BCP‐ALL) is a disease with specific secondary genetic alterations such as mutations (eg…”
Get full text
Journal Article -
17
S896 SYNTHETIC LETHAL EFFECTS OF DUAL BCR AND PARP INHIBITION IN PROLIFERATIVE DEL(11Q) CLL CELLS IN THE PRESENCE OF STROMAL STIMULATION
Published in HemaSphere (01-06-2019)“…Background: Loss of the long arm of chromosome 11, del(11q), is one of the most common alterations in CLL. ATM gene is mutated in the remaining allele in one…”
Get full text
Journal Article -
18
MUTATIONS ON COHESIN COMPLEX ARE ASSOCIATED TO A POOR PROGNOSIS IN LOW-RISK MYELODYSPLASTIC SYNDROMES PATIENTS: PF533
Published in HemaSphere (01-06-2019)Get full text
Journal Article -
19
PB2080 ROLE OF SOMATIC MUTATIONS IN PATIENTS WITH HIGH‐RISK MYELODISPLASTIC SYNDROMES TREATED WITH INTENSIVE CHEMOTHERAPY
Published in HemaSphere (01-06-2019)“…Background: Next Generation Sequencing (NGS) identify somatic mutations in driver genes in up to 90% of patients with MDS. Intensive Chemotherapy (IC) is…”
Get full text
Journal Article -
20
PF533 MUTATIONS ON COHESIN COMPLEX ARE ASSOCIATED TO A POOR PROGNOSIS IN LOW‐RISK MYELODYSPLASTIC SYNDROMES PATIENTS
Published in HemaSphere (01-06-2019)“…Background: Mutations in cohesin complex genes have been described commonly in several types of cancer, with an incidence of 8% in myeloid diseases and…”
Get full text
Journal Article